Mechanistically, miR-146a inhibits GBM cell stemness by directly targeting POU3F2 and SMARCA5, two transcription factors that reciprocally regulate each other and whose expression levels are positively correlated in GBM. The gene discussed is SMARCA5; the disease is glioblastoma.